Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 7/20 | 0.45 |
| ▸ | COMT | P21964 | 6/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.34 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32669844 | 0.95 | FTO (0.47) | FTOCOMTTP53ABCB1ABCC1 | |
| SCHEMBL32669508 | 0.94 | FTO (0.52) | FTOCOMTTP53ABCB1ABCC1 | |
| SCHEMBL32669519 | 0.92 | FTO (0.44) | FTOCOMTTP53ABCB1ABCC1 | |
| SCHEMBL32670035 | 0.91 | FTO (0.47) | FTOCOMTABCB1ABCC1CYP11B1 | |
| SCHEMBL32669700 | 0.89 | COMT (0.42) | FTOCOMTTP53ABCB1ABCC1 | |
| SCHEMBL32669753 | 0.88 | ABCB1 (0.36) | ABCB1ABCC1CYP11B1CYP11B2 | |
| SCHEMBL32669833 | 0.85 | FTO (0.58) | FTOCOMTTP53ABCB1ABCC1 | |
| SCHEMBL32669953 | 0.83 | FTO (0.46) | FTOCOMTMEN1KMT2A | |
| SCHEMBL32669960 | 0.81 | FTO (0.53) | FTOCOMTTP53MAPTMEN1 | |
| SCHEMBL32669975 | 0.79 | FTO (0.59) | FTOCOMTTP53ABCB1ABCC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035341-A1 | FTO INHIBITORS | RPXDS CO LTD (CN) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035341-A1 | FTO INHIBITORS | FTO, LDLR, GPR119 | FTO 1/4885COMT 52/4885TP53 4038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.